Key facts
- This page summarizes Douglas Plassche's Form 4 filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Jan 2026, 16:35.
Douglas Plassche - 09 Jan 2026 Form 4 Insider Report for ELITE PHARMACEUTICALS INC /NV/ (ELTP)
- Reporting relationship
- EVP Operations
- Issuer ticker
- ELTP
- Reported as of
- 09 Jan 2026
- Net transaction value
- +$75,000
- SEC form
- 4
- Accepted by SEC
- 13 Jan 2026, 16:35:20 UTC
- Prior SEC filing
- 03 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Douglas Plassche
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Douglas Plassche filed Form 4 for ELITE PHARMACEUTICALS INC /NV/ (ELTP) on 13 Jan 2026.
Change
- Previous filing in this sequence was filed on 03 Oct 2025.
- Current net transaction value: +$75,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001600946
Primary reporting owner
Plassche Douglas
- Relationship
- EVP Operations
- Address
- 165 LUDLOW AVE., NORTHVALE
- Signature
- /s/ Douglas Plassche
- Signature date
- 13 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELTP
transaction
Stock Options (right to buy)
Options Exercise
- Transaction value
- $75,000
- Shares
- +2,500,000
- Change %
- +71%
- Price
- $0.0300
- Shares after
- 6,000,000
- Date
- 09 Jan 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELTP
transaction
Derivative
Stock Options (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,500,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 09 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500,000
- Exercise price
- $0.0300
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
All of the stock options were fully vested and exercisable as of the transaction date.